MOESM1 of The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis

Additional file 1: Figure S1. Sensitivity analyses to evaluate stability of meta-analysis by omitting each study. (A) Sensitivity analysis for pooled risk ratio (RR) of objective response rate (ORR); (B) sensitivity analysis for pooled hazard ratio (HR) of progression-free survival (PFS); (C) sensitivity analysis for pooled HR of overall survival (OS); (D) sensitivity analysis of pooled OR of total treatment-related adverse event; (E) sensitivity analysis of pooled OR of grade 3–4 treatment-related adverse event.